NASDAQ:ARDS Aridis Pharmaceuticals Earnings Date & Estimates $0.0001 0.00 (0.00%) As of 01:31 PM Eastern Aridis Pharmaceuticals is estimated to report earnings on Thursday, November 19, 2026. Research:Profile Upcoming Earnings Announcement Announcement DateNovember 19, 2026 Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Aridis PharmaceuticalsAridis Pharmaceuticals is expected to post earnings of -$0.5960 per share on revenue of $267 thousand. Aridis Pharmaceuticals has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.5960Expected Revenue$267 thousandRecent Track RecordLast ReportedQ3 2023Last Quarter EPS-$0.02Last Quarter Revenue$420 thousandEPS Beat Rate2 of last 8 quartersPrepare for the Earnings CallCompany ProfileQ3 2023 Earnings ReportQ2 2023 Earnings ReportQ1 2023 Earnings Report Aridis Pharmaceuticals Earnings FAQ When does Aridis Pharmaceuticals report earnings? Aridis Pharmaceuticals (NASDAQ:ARDS) is estimated to report earnings on Thursday, November 19, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Aridis Pharmaceuticals? Analysts expect Aridis Pharmaceuticals to post earnings of -$0.5960 per share for the quarter. How much revenue is Aridis Pharmaceuticals expected to report? The consensus revenue estimate for Aridis Pharmaceuticals is $267 thousand for the quarter. Aridis Pharmaceuticals Earnings HeadlinesAridis Pharmaceuticals, Inc. (ARDS) - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comAridis Provides Corporate UpdateDecember 20, 2024 | globenewswire.comTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.November 19 at 1:00 AM | Base Camp Trading (Ad)Horizon Tech Finance (NASDAQ:HRZN) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comGenor Biopharma Holdings Limited (67N0.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comBreathing easier: Nature-inspired treatments could relieve acute respiratory distressAugust 3, 2024 | msn.comSee More Aridis Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Aridis Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aridis Pharmaceuticals and other key companies, straight to your email. Email Address About Aridis PharmaceuticalsAridis Pharmaceuticals (NASDAQ:ARDS) is a biopharmaceutical company focused on developing antibody-based treatments for infectious diseases, particularly serious bacterial and respiratory infections. Its work has included therapies intended to complement antibiotics by targeting toxins or other components of disease-causing bacteria. The company’s research programs have included AR-301, a monoclonal antibody targeting Staphylococcus aureus alpha toxin, investigated as a potential treatment for severe pneumonia. Aridis has also developed other antibody candidates for infectious diseases using its antibody-discovery technologies. Founded in 2003 and based in San Jose, California, Aridis was founded by Vu Truong, who has served as the company’s chief executive officer. Its development programs have been conducted primarily in the United States.View Aridis Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.